Wang Yingfei, An Ran, Umanah George K, Park Hyejin, Nambiar Kalyani, Eacker Stephen M, Kim BongWoo, Bao Lei, Harraz Maged M, Chang Calvin, Chen Rong, Wang Jennifer E, Kam Tae-In, Jeong Jun Seop, Xie Zhi, Neifert Stewart, Qian Jiang, Andrabi Shaida A, Blackshaw Seth, Zhu Heng, Song Hongjun, Ming Guo-Li, Dawson Valina L, Dawson Ted M
Neuroregeneration and Stem Cell Programs, Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Science. 2016 Oct 7;354(6308). doi: 10.1126/science.aad6872.
Inhibition or genetic deletion of poly(ADP-ribose) (PAR) polymerase-1 (PARP-1) is protective against toxic insults in many organ systems. The molecular mechanisms underlying PARP-1-dependent cell death involve release of mitochondrial apoptosis-inducing factor (AIF) and its translocation to the nucleus, which results in chromatinolysis. We identified macrophage migration inhibitory factor (MIF) as a PARP-1-dependent AIF-associated nuclease (PAAN). AIF was required for recruitment of MIF to the nucleus, where MIF cleaves genomic DNA into large fragments. Depletion of MIF, disruption of the AIF-MIF interaction, or mutation of glutamic acid at position 22 in the catalytic nuclease domain blocked MIF nuclease activity and inhibited chromatinolysis, cell death induced by glutamate excitotoxicity, and focal stroke. Inhibition of MIF's nuclease activity is a potential therapeutic target for diseases caused by excessive PARP-1 activation.
抑制或基因敲除聚(ADP - 核糖)(PAR)聚合酶 -1(PARP -1)可在许多器官系统中抵御毒性损伤。PARP -1依赖性细胞死亡的分子机制涉及线粒体凋亡诱导因子(AIF)的释放及其向细胞核的转位,这会导致染色质溶解。我们将巨噬细胞迁移抑制因子(MIF)鉴定为一种PARP -1依赖性AIF相关核酸酶(PAAN)。AIF是MIF募集到细胞核所必需的,在细胞核中MIF将基因组DNA切割成大片段。MIF的缺失、AIF - MIF相互作用的破坏或催化核酸酶结构域中第22位谷氨酸的突变会阻断MIF核酸酶活性,并抑制染色质溶解、谷氨酸兴奋性毒性诱导的细胞死亡以及局灶性中风。抑制MIF的核酸酶活性是由PARP -1过度激活引起的疾病的潜在治疗靶点。